343
Participants
Start Date
October 10, 2007
Primary Completion Date
April 29, 2020
Study Completion Date
April 29, 2020
Bevacizumab
2.5 mg/kg By Vein Over 90 Minutes.
Sorafenib
200 mg By Mouth Daily for 28 Days
Erlotinib
50 mg By Mouth Daily for 28 Days.
Trastuzumab
Loading 2 mg/kg by vein then Maintenance 1 mg/kg by vein on Day 1
Lapatinib
250 mg By Mouth Daily for 21 Days.
Sunitinib
12.5 mg orally daily for 4 weeks, then 2 weeks off.
Cetuximab
Loading 100 mg/m² by vein and Maintenance 75 mg/m² by vein on Days 1, 8, 15, 22
University of Texas MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER